| Net Cash Provided by (Used in) Operating Activities |
$3,000,000 |
USD |
-101% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$40,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$50,000,000 |
USD |
43% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
324,000,000 |
shares |
0.12% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,000,000 |
USD |
-118% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$332,000,000 |
USD |
39% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$60,000,000 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$52,000,000 |
USD |
2% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$544,000,000 |
USD |
-5.6% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$1,398,000,000 |
USD |
-3.2% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$147,000,000 |
USD |
-52% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$1,730,000,000 |
USD |
-5.9% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$2,765,000,000 |
USD |
11% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$253,000,000 |
USD |
14% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0575 |
pure |
-0.86% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$332,000,000 |
USD |
-16% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$29,000,000 |
USD |
-24% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$15,000,000 |
USD |
-46% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$411,000,000 |
USD |
7% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$492,000,000 |
USD |
-6.3% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$8,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$260,000,000 |
USD |
-47% |
Q3 2024 |
Q3 2024 |